Friends in Congress helped drug compounders avoid tighter rules

The New York Times, November 15, 2012
Despite two decades of dire health warnings and threats of federal intervention, the specialty drugmakers have repeatedly staved off tougher federal oversight with the help of powerful allies in Congress. Over the years, industry friends like Tom DeLay, the former House Republican leader from Texas, have come to its defense. Even Senator Edward M. Kennedy, regarded as the strongest healthcare advocate in Congress in recent times, dropped efforts to impose new safeguards. The pharmacists known as compounders are now facing their biggest regulatory threat as they confront questions at Congressional hearings on the deadly outbreak. The question is whether Congress will move to oversee the niche industry more aggressively.

MOST POPULAR

" style="font-family:inherit">Physician's Scathing Remarks Humiliate Patient, Cost Hospital
  • Alternative Staffing Arrangements
  • " style="font-family:inherit">The Perils of Cut-and-Paste Documentation
  • Aging Doctors: Time for Mandatory Competency Testing?
  • 7 Years In, Triple Aim Transcends Jargon
  • Alternative Staffing Arrangements
  • CMS Predictive Readmission Models 'Not Very Good'
  • SPONSORED REPORTS
    SPONSORED HEADLINES

    SIGN UP

    FREE e-Newsletters Join the Council Subscribe to HL magazine

    SPONSORSHIP & ADVERTISING

    100 Winners Circle Suite 300
    Brentwood, TN 37027

    800-727-5257

    About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
    © HealthLeaders Media 2014 a division of BLR All rights reserved.